Influence of particle size on drug delivery to rat alveolar macrophages following pulmonary administration of ciprofloxacin incorporated into liposomes

References

• Alving CR, Steck EA, Chapman WL, Jr, Waits VB, Hendricks LD, Swartz GM, Jr, Hanson WL. Liposomes in leishmaniasis: Therapeutic effects of antimonial drugs, 8-aminoquinolines, and tetracycline. Life Sci 1980; 26: 2231–2238
   PubMed Web of Science ®Google Scholar
• Antonini JM, Reasor MJ. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem Pharmacol 1991; 42: S151–S156
   PubMed Web of Science ®Google Scholar
• Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13: 238–252
   PubMed Web of Science ®Google Scholar
• Benne CA, Benaissa-Trouw B, van Strijp JA, Kraaijeveld CA, van Iwaarden JF. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis: Binding and neutralization. Eur J Immunol 1997; 27: 886–890
   PubMed Web of Science ®Google Scholar
• Branford MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Chono S, Tauchi Y, Deguchi Y, Morimoto K. Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice. J Drug Target 2005; 13: 267–276
   PubMed Web of Science ®Google Scholar
• Chono S, Tauchi Y, Morimoto K. Influence of particle size on the distributions of liposomes to atherosclerotic lesions in mice. Drug Dev Ind Pharm 2006; 32: 125–135
   PubMed Web of Science ®Google Scholar
• Decker T, Lohmann-Matthes ML. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988; 115: 61–69
   PubMed Web of Science ®Google Scholar
• Deol P, Khuller GK, Joshi K. Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice. Antimicrob Agents Chemother 1997; 41: 1211–1214
   PubMed Web of Science ®Google Scholar
• Derksen JT, Morselt HW, Scherphof GL. Processing of different liposomal markers after in vitro uptake of immunoglobulin-coated liposomes by rat liver macrophages. Biochim Biophys Acta 1987; 931: 33–40
   PubMed Web of Science ®Google Scholar
• Doganay M. Listeriosis: Clinical presentation. FEMS Immunol Med Microbiol 2003; 35: 173–175
   PubMed Web of Science ®Google Scholar
• Dubois J, St-Pierre C. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp. J Antimicrob Chemother 2000; 45: 41–46
   PubMed Web of Science ®Google Scholar
• Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution. J Infect Dis 1991; 163: 1326–1335
   PubMed Web of Science ®Google Scholar
• Ferdous AJ, Ishida T, Shinohara M, Harashima H, Kiwada H. Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma. Biopharm Drug Dispos 1996; 17: 145–154
   PubMed Web of Science ®Google Scholar
• Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 1999; 14: 435–447
   Web of Science ®Google Scholar
• Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362: 887–899
   PubMed Web of Science ®Google Scholar
• Funato K, Yoda R, Kiwada H. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochim Biophys Acta 1992; 1103: 198–204
   PubMed Web of Science ®Google Scholar
• Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004; 17: 413–433
   PubMed Web of Science ®Google Scholar
• Harashima H, Sakata K, Funato K, Kiwada H. Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharmaceu Res 1994; 11: 402–406
   Web of Science ®Google Scholar
• Harashima H, Houng TM, Ishida T, Manabe Y, Matsuo H, Kiwada H. Synergistic effect between size and cholesterol content in enhanced hepatic uptake clearance of liposomes through complement activation in rats. Pharmaceu Res 1996; 13: 1704–1709
   Web of Science ®Google Scholar
• Harashima H, Iida S, Urakami Y, Tsuchihashi M, Kiwada H. Optimization of antitumor effect of liposomally encapsulated doxorubicin based on simulations by pharmacokinetic/pharmacodynamic modeling. J Control Release 1999; 61: 93–106
   PubMed Web of Science ®Google Scholar
• Harb OS, Gao LY, Abu Kwaik Y. From protozoa to mammalian cells: A new paradigm in the life cycle of intracellular bacterial pathogens. Environ Microbiol 2000; 2: 251–265
   PubMed Web of Science ®Google Scholar
• Harnett SJ, Fraise AP, Andrews JM, Jevons G, Brenwald NP, Wise R. Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492. J Antimicrob Chemother 2004; 53: 783–792
   PubMed Web of Science ®Google Scholar
• Holmskov U, Mollenhauer J, Madsen J, Vitved L, Gronlund J, Tornoe I, Kliem A, Reid KB, Poustka A, Skjodt K. Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D. Proc Natl Acad Sci USA 1999; 96: 10794–10799
   PubMed Web of Science ®Google Scholar
• Houng TM, Harashima H, Kiwada H. Complement dependent and independent liposome uptake by peritoneal macrophages: Cholesterol content dependency. Biol Pharm Bull 1998; 21: 969–973
   PubMed Web of Science ®Google Scholar
• Houng TM, Harashima H, Kiwada H. In vivo studies on the role of complement in the clearance of liposomes in rats and guinea pigs. Biol Pharm Bull 1999; 22: 515–520
   PubMed Web of Science ®Google Scholar
• Hsu MJ, Juliano RL. Interactions of liposomes with the reticuloendothelial system. II: Nonspecific and receptor-mediated uptake of liposomes by mouse peritoneal macrophages. Biochim Biophys Acta 1982; 720: 411–419
   PubMed Web of Science ®Google Scholar
• Ikaheimo I, Syrjala H, Karhukorpi J, Schildt R, Koskela M. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J Antimicrob Chemother 2000; 46: 287–290
   PubMed Web of Science ®Google Scholar
• Kohno Y, Yoshida H, Suwa T, Suga T. Uptake of clarithromycin by rat lung cells. J Antimicrob Chemother 1990; 26: 503–513
   PubMed Web of Science ®Google Scholar
• Magallanes M, Dijkstra J, Fierer J. Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob Agents Chemother 1993; 37: 2293–2297
   PubMed Web of Science ®Google Scholar
• McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs WR, Jr, Russell DG. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000; 406: 735–738
   PubMed Web of Science ®Google Scholar
• Nara C, Tateda K, Matsumoto T, Ohara A, Miyazaki S, Standiford TJ, Yamaguchi K. Legionella-induced acute lung injury in the setting of hyperoxia: Protective role of tumour necrosis factor-alpha. J Med Microbiol 2004; 53: 727–733
   PubMed Web of Science ®Google Scholar
• Onodera Y, Tanaka M, Sato K. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis. J Antimicrob Chemother 2001; 47: 447–450
   PubMed Web of Science ®Google Scholar
• Pan XS, Fisher LM. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones. Antimicrob Agents Chemother 1997; 41: 471–474
   PubMed Web of Science ®Google Scholar
• Perry DG, Wisniowski P, Daugherty GL, Downing J, Martin WJ, 2nd. Nonimmune phagocytosis of liposomes by rat alveolar macrophages is enhanced by vitronectin and is vitronectin-receptor mediated. Am J Respir Cell Mol Biol 1997; 17: 462–470
   PubMed Web of Science ®Google Scholar
• Pool GL, French ME, Edwards RA, Huang L, Lumb RH. Use of radiolabeled hexadecyl cholesterol ester as a liposome marker. Lipids 1982; 17: 445–452
   Web of Science ®Google Scholar
• Portnoy DA, Chakraborty T, Goebel W, Cossart P. Molecular determinants of Listeria monocytogenes pathogenesis. Infect Immun 1992; 60: 1263–1267
   PubMed Web of Science ®Google Scholar
• Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin PG, Crystal RG. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60: 532–538
   PubMed Web of Science ®Google Scholar
• Safdar A, Armstrong D. Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955–1997). J Clin Microbiol 2003; 41: 483–485
   PubMed Web of Science ®Google Scholar
• Schagat TL, Wofford JA, Wright JR. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol 2001; 166: 2727–2733
   PubMed Web of Science ®Google Scholar
• Smith HJ, Nichol KA, Hoban DJ, Zhanel GG. Stretching the mutant prevention concentration (MPC) beyond its limits. J Antimicrob Chemother 2003; 51: 1323–1325
   PubMed Web of Science ®Google Scholar
• Snider DE, Jr, La Montagne JR. The neglected global tuberculosis problem: A report of the 1992 World Congress on Tuberculosis. J Infect Dis 1994; 169: 1189–1196
   PubMed Web of Science ®Google Scholar
• Takahata M, Mitsuyama J, Yamashiro Y, Yonezawa M, Araki H, Todo Y, Minami S, Watanabe Y, Narita H. In vitro and in vivo antimicrobial activities of T-3811ME, a novel des-F(6)-quinolone. Antimicrob Agents Chemother 1999; 43: 1077–1084
   PubMed Web of Science ®Google Scholar
• Tarnvik A, Berglund L. Tularaemia. Eur Respir J 2003; 21: 361–373
   PubMed Web of Science ®Google Scholar
• Tomioka H, Sato K, Kajitani H, Akaki T, Shishido S. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex. Antimicrob Agents Chemother 2000; 44: 283–286
   PubMed Web of Science ®Google Scholar
• Tsai MH, Huang YC, Chen CJ, Lin PY, Chang LY, Chiu CH, Tsao KC, Huang CG, Lin TY. Chlamydial pneumonia in children requiring hospitalization: Effect of mixed infection on clinical outcome. J Microbiol Immunol Infect 2005; 38: 117–122
   PubMedGoogle Scholar
• Tsuchihashi M, Harashima H, Kiwada H. Development of a pharmacokinetic/pharmacodynamic (PK/PD)-simulation system for doxorubicin in long circulating liposomes in mice using peritoneal P388. J Control Release 1999; 61: 9–19
   PubMed Web of Science ®Google Scholar
• Vazquez-Boland JA, Kuhn M, Berche P, Chakraborty T, Dominguez-Bernal G, Goebel W, Gonzalez-Zorn B, Wehland J, Kreft J. Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev 2001; 14: 584–640
   PubMed Web of Science ®Google Scholar
• Vyas SP, Kannan ME, Jain S, Mishra V, Singh P. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 2004; 269: 37–49
   PubMed Web of Science ®Google Scholar
• Vyas SP, Quraishi S, Gupta S, Jaganathan KS. Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages. Int J Pharm 2005; 296: 12–25
   PubMed Web of Science ®Google Scholar
• Yee D, Valiquette C, Pelletier M, Parisien I, Rocher I, Menzies D. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. Am J Respir Crit Care Med 2003; 167: 1472–1477
   PubMed Web of Science ®Google Scholar